Ignite Creation Date:
2024-05-06 @ 1:57 PM
Last Modification Date:
2024-10-26 @ 1:22 PM
Study NCT ID:
NCT04175522
Status:
COMPLETED
Last Update Posted:
2020-06-30
First Post:
2019-11-21
Brief Title:
Safety and Efficacy of IGIV 10 in Patients With Autoimmune Encephalitis
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp
Study Overview
Official Title:
A Phase 2a Prospective Open-label Single-arm Single Center Proof of Concept Study to Evaluate the Safety and Efficacy of IGIV 10 in Patients With Autoimmune Encephalitis
Status:
COMPLETED
Status Verified Date:
2020-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety and efficacy of IGIV 10 in patients with autoimmune encephalitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None